Prescription Drugs: Misuse, Addiction, Risks, and Treatment

Prescription drug misuse means taking medication in a way, amount, frequency, duration, or purpose that a clinician did not direct. Prescription drug addiction is an umbrella term for a substance use disorder involving a prescribed medication, impaired control, and continued use despite harm. A valid prescription does not prove addiction, and obtaining medication without a prescription does not by itself establish a diagnosis.

Prescription medicines can relieve pain, reduce anxiety, support sleep, prevent seizures, or improve attention when used as directed. The same medicines can produce intoxication, tolerance, physical dependence, withdrawal, overdose, or a use disorder, but those outcomes are not interchangeable.

What are prescription drugs?

Prescription drugs are medications that require authorization from a licensed prescriber because their benefits, doses, interactions, and risks require clinical oversight. The category includes thousands of medicines, while prescription-drug misuse research usually focuses on opioid pain relievers, tranquilizers and sedatives, and stimulants.

Prescription status describes how a medicine is supplied; it does not describe one pharmacologic effect or one addiction risk. An opioid suppresses pain and breathing, a benzodiazepine amplifies inhibitory signaling, and a stimulant increases alertness and cardiovascular activity.

Clinical perspective

Prescription drug addiction has a different emotional texture than illicit drug addiction, because it usually started with a doctor's signature, not a bad decision. A lot of people carry real shame about that even though the path into dependence was medically sanctioned. Separating how the addiction started from how much responsibility someone should carry for it now is part of the work treatment has to do early on.

How do prescribed use, misuse, dependence, and addiction differ?

Prescribed use follows clinical directions, misuse departs from those directions, physical dependence reflects adaptation, and addiction reflects impaired control despite harm. SAMHSA defines misuse to include use without one's own prescription, use in greater amounts, use more often or longer than directed, or use in another way a clinician did not direct.

• Tolerance: the same dose produces less effect, or a larger dose is needed to produce the previous effect.
• Physical dependence: the body adapts to repeated exposure and develops withdrawal after a rapid reduction or stop.
• Substance use disorder: a pattern of impaired control, hazardous use, functional disruption, or continued use despite consequences causes clinically significant impairment or distress.

Tolerance and dependence can occur while a patient follows a prescription and do not automatically establish addiction. Diagnosis requires the broader pattern, the clinical context, and the medication class.

Which prescription drugs are commonly misused?

Prescription opioids, tranquilizers and sedatives, and stimulants are the principal psychotherapeutic medication groups measured in national misuse data. Each group has legitimate medical uses, distinct pharmacology, and a different pattern of intoxication, withdrawal, and treatment.

Prescription medication groups, examples, and major acute risks

Medication group	Examples	Major acute risks
Opioid pain relievers	Oxycodone, hydrocodone, morphine	Respiratory depression, loss of consciousness, overdose
Tranquilizers and sedatives	Alprazolam, clonazepam, diazepam, zolpidem	Profound sedation, impaired coordination, memory loss, dangerous withdrawal
Prescription stimulants	Amphetamine, lisdexamfetamine, methylphenidate	Rapid heart rate, high blood pressure, agitation, hyperthermia, psychosis

Prescription pain relievers in the national survey are primarily opioids. Opioid use disorder differs from expected pain treatment and physical dependence because the diagnosis requires a harmful pattern of opioid use.

Benzodiazepines are one subgroup within tranquilizers and sedatives. Their ability to reduce anxiety and seizure activity also creates sedation, dependence, and potentially life-threatening withdrawal, so benzodiazepine risks require a class-specific assessment.

Lean, or purple drank, combines prescription codeine-promethazine cough syrup with soda, exposes the user to an opioid and a sedating antihistamine, and creates respiratory-depression risk that the drink's sweet flavor does not reveal.

How common is prescription drug misuse in the United States?

SAMHSA estimated that 12.8 million people age 12 or older misused a prescription psychotherapeutic drug during 2025. That total included 6.9 million people who misused prescription opioids, 4.2 million who misused prescription tranquilizers or sedatives, and 3.9 million who misused prescription stimulants.

The medication groups overlap because one person can report more than one category, so the three subgroup estimates must not be added together. The survey measures self-reported misuse during a defined period; it does not count every person with physical dependence or prove that every episode met criteria for a substance use disorder.

What signs can indicate prescription drug addiction?

Prescription drug addiction can cause impaired control, compulsive medication seeking, risky use, and continued use despite physical, psychological, or social harm. Warning signs include taking larger or earlier doses, seeking repeated early refills, obtaining the same class from multiple sources, hiding use, repeatedly failing to reduce use, and allowing medication use to displace work, school, relationships, or usual activities.

Physical findings depend on the medication. Opioids can produce pinpoint pupils, constipation, drowsiness, and slow breathing; sedatives can produce slurred speech, poor coordination, memory impairment, and excessive sleepiness; stimulants can produce insomnia, appetite loss, agitation, chest pain, rapid heart rate, and high body temperature.

No single sign proves addiction. A refill request can reflect undertreated symptoms, tolerance can occur during appropriate care, and withdrawal can reflect expected dependence, so a clinician must assess behavior, function, exposure, and harm together.

When does prescription drug use become a medical emergency?

Unresponsiveness, slow or stopped breathing, blue or gray lips, a seizure, severe chest pain, extreme agitation, very high body temperature, or sudden confusion requires emergency care. Call 911, describe the medications or substances that may be involved, and stay with the person until responders arrive.

When an opioid may be involved, naloxone administration can temporarily reverse opioid effects. Give the medicine if it is available, support breathing if trained, repeat the dose according to the product directions when the person does not respond, and continue emergency monitoring even after improvement.

Combining an opioid or benzodiazepine with alcohol, sleep medication, or another central nervous system depressant can produce profound sedation, respiratory depression, coma, and death. Naloxone reverses an opioid component; it does not reverse benzodiazepine or alcohol effects.

How is prescription drug addiction assessed?

A prescription drug assessment identifies the medication, formulation, dose, route, frequency, duration, source, co-exposures, withdrawal risk, overdose history, and effect on daily function. The clinician also evaluates pain, anxiety, sleep, attention, trauma, mood, and other conditions that may have preceded or followed the medication use.

Medication reconciliation, prescription-monitoring records, physical examination, and targeted toxicology can clarify exposure when each tool is clinically useful. A test result can support assessment, but it cannot show dose, impairment, prescribed intent, or a substance use disorder by itself.

What action fits a prescription-drug safety concern?

The next step depends on whether the concern is an emergency, a dangerous withdrawal risk, a stable pattern of misuse, or medication that should no longer be used. Medication class, symptoms, co-exposures, and medical stability determine the appropriate response.

How is prescription drug addiction treated?

Treatment stabilizes immediate medical risk, treats the class-specific use disorder, and continues care for the condition the medication was intended to address. The plan can include medically supervised withdrawal, medication, cognitive behavioral therapy, contingency management, motivational interventions, family work, peer support, and recovery services.

Opioid use disorder can be treated with buprenorphine, methadone, or naltrexone; benzodiazepine dependence usually requires an individualized gradual taper when discontinuation is indicated; stimulant use disorder relies primarily on behavioral treatment because no medication has FDA approval specifically for that disorder. A prescription drug addiction treatment program can coordinate outpatient therapy and continuing care after emergency stabilization or external withdrawal management.

Treatment intensity follows withdrawal danger, overdose history, medical stability, psychiatric symptoms, home support, and functional impairment. One medication category cannot supply the treatment plan for another, and abrupt discontinuation can create avoidable harm.

How do co-occurring conditions change prescription drug treatment?

Co-occurring pain, anxiety, insomnia, trauma, depression, or attention symptoms change treatment because the original clinical need remains even when medication use becomes unsafe. Removing a medicine without treating its function can intensify symptoms, destabilize recovery, and increase the risk of resumed use.

Dual diagnosis treatment coordinates substance-use care with psychiatric assessment, therapy, medication review, sleep support, and pain management. The goal is not to deny necessary treatment; the goal is to reduce harmful use while preserving effective care.

How can prescription drug misuse be prevented?

Prevention combines accurate prescribing, one current medication list, interaction review, secure storage, patient education, and prompt disposal of unused medication. Patients should take the labeled dose, avoid sharing medicine, ask before mixing prescriptions with alcohol or over-the-counter products, and report sedation, escalating use, early withdrawal, or difficulty controlling use.

Prescribers can reassess benefit and risk, review prescription drug monitoring data, screen for substance-use risk, discuss naloxone when opioid exposure creates overdose risk, and plan a gradual reduction when stopping a dependence-forming medicine is appropriate. Families can respond to changed behavior without shaming the person or attempting to manage dangerous withdrawal alone.

What are common questions about prescription drugs?

Common prescription-drug questions distinguish prescribed use, expected physical dependence, misuse, addiction, withdrawal, and safe disposal. The medication class, pattern of use, symptoms, and interaction risks determine which answer applies.

Can a person develop addiction while following a prescription?

Yes. A substance use disorder can develop during medical treatment, although careful selection, monitoring, and follow-up can reduce risk. Prescribed use alone does not prove addiction.

Does needing a higher dose mean a person is addicted?

No. A higher dose request can reflect tolerance, worsening symptoms, or another clinical problem. Addiction requires a broader pattern of impaired control and continued harmful use.

Should someone stop a misused prescription immediately?

Not without clinical guidance. Abrupt opioid discontinuation can cause serious withdrawal and other harms, while abrupt benzodiazepine discontinuation can cause life-threatening seizures. A clinician should identify the medicine, assess the risk, and create a class-specific plan.